Chesapeake (CHK) Could Be Worth 4x More Based Oppenheimer's 'Conservative' NAV Estimate
Get Alerts CHK Hot Sheet
Price: $91.47 +0.86%
Rating Summary:
18 Buy, 18 Hold, 9 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
18 Buy, 18 Hold, 9 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Oppenheimer has come out with a vigorous defense of Chesapeake Energy (NYSE: CHK) Tuesday, saying the panic sell-off is a buying opportunity.
Despite the relentless attacks by the media, the firm believes Chesapeake's net asset value, after the pending asset sales, is "several times its current share price".
Chesapeake believes its net asset value is in the $50-60B range, or $75-90/share. Oppenheimer doesn't got quite this far but conservatively estimates net asset value in the $22-37B range, or $39-63/share.
Th company has completed $2.6B in transactions YTD and is on track to complete an additional $9.0-11.5B in 2012. Proceeds are expected to fully fund 2012 capex and reduce debt to $9.5B by year-end 2012.
For an analyst ratings summary and ratings history on Chesapeake Energy click here. For more ratings news on Chesapeake Energy click here.
Shares of Chesapeake Energy closed at $14.91 yesterday.
Despite the relentless attacks by the media, the firm believes Chesapeake's net asset value, after the pending asset sales, is "several times its current share price".
Chesapeake believes its net asset value is in the $50-60B range, or $75-90/share. Oppenheimer doesn't got quite this far but conservatively estimates net asset value in the $22-37B range, or $39-63/share.
Th company has completed $2.6B in transactions YTD and is on track to complete an additional $9.0-11.5B in 2012. Proceeds are expected to fully fund 2012 capex and reduce debt to $9.5B by year-end 2012.
For an analyst ratings summary and ratings history on Chesapeake Energy click here. For more ratings news on Chesapeake Energy click here.
Shares of Chesapeake Energy closed at $14.91 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho on Intel (INTC): "Just when you thought it could not get any worse..."
- Teradyne (TER) PT Raised to $125 at TD Cowen
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
Create E-mail Alert Related Categories
Analyst Comments, Hot CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!